Ascendis Pharma A/S Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 10.28 M | $1.60 B | 1.67% | 17.13% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 05/09/2025 | 5.48 M | $854.00 M | -0.89% | 9.13% |
AVORO CAPITAL ADVISORS LLC | 05/15/2025 | 5.22 M | $813.28 M | 2.25% | 8.69% |
FMR LLC | 05/12/2025 | 4.67 M | $728.32 M | -1.18% | 7.79% |
JANUS HENDERSON GROUP PLC | 05/15/2025 | 4.49 M | $693.95 M | 2.43% | 7.48% |
ARTISAN PARTNERS LIMITED PARTNERSHIP | 05/14/2025 | 4.26 M | $663.44 M | -4.35% | 7.09% |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/14/2025 | 3.05 M | $475.97 M | 12.04% | 5.09% |
CAPITAL INTERNATIONAL INVESTORS | 05/12/2025 | 2.87 M | $448.07 M | 0.40% | 4.79% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 2.26 M | $351.64 M | -1.19% | 3.76% |
MORGAN STANLEY | 05/15/2025 | 1.90 M | $296.68 M | 130.52% | 3.17% |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 05/02/2025 | 1.88 M | $292.69 M | 0.56% | 3.13% |
FRANKLIN RESOURCES INC | 05/13/2025 | 1.64 M | $255.63 M | 20.92% | 2.73% |
INVESCO LTD. | 05/12/2025 | 1.20 M | $186.79 M | 3.67% | 2.00% |
CITADEL ADVISORS LLC | 05/15/2025 | 1.13 M | $175.37 M | 25.58% | 1.87% |
AMERIPRISE FINANCIAL INC | 05/14/2025 | 679.94 K | $105.98 M | -3.22% | 1.13% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 587.76 K | $91.61 M | -16.53% | 0.98% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 585.58 K | $91.27 M | 10.40% | 0.98% |
POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 569.15 K | $88.71 M | 13.00% | 0.95% |
POLAR CAPITAL HOLDINGS PLC | 05/15/2025 | 525.00 K | $81.83 M | 75.00% | 0.87% |
BLACKROCK, INC. | 05/02/2025 | 517.15 K | $80.60 M | -20.84% | 0.86% |
FIL LTD | 05/12/2025 | 462.37 K | $72.06 M | -36.60% | 0.77% |
AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 462.17 K | $72.03 M | 13.47% | 0.77% |
ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 432.10 K | $67.35 M | -2.91% | 0.72% |
GROUPAMA ASSET MANAGMENT | 05/14/2025 | 400.00 K | $482.38 K | 0.00% | 0.67% |
CAMBER CAPITAL MANAGEMENT LP | 05/15/2025 | 350.00 K | $54.55 M | -56.25% | 0.58% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 346.02 K | $53.93 M | 15.73% | 0.58% |
TD ASSET MANAGEMENT INC | 05/07/2025 | 343.39 K | $53.52 M | 1.10% | 0.57% |
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2025 | 330.15 K | $51.46 M | 4.29% | 0.55% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 327.41 K | $51.03 M | 100.00% | 0.55% |
WOODLINE PARTNERS LP | 05/15/2025 | 304.81 K | $47.51 M | -4.04% | 0.51% |
SIREN, L.L.C. | 05/23/2025 | 287.37 K | $44.79 M | -3.35% | 0.48% |
ARS INVESTMENT PARTNERS, LLC | 05/14/2025 | 265.16 K | $36.51 M | -0.12% | 0.44% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 264.87 K | $41.28 M | -26.04% | 0.44% |
SEI INVESTMENTS CO | 05/14/2025 | 258.01 K | $40.21 M | -2.11% | 0.43% |
Q GLOBAL ADVISORS, LLC | 05/14/2025 | 248.89 K | $38.79 M | 13.41% | 0.41% |
CANDRIAM S.C.A. | 05/14/2025 | 242.76 K | $37.84 M | -13.35% | 0.40% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2025 | 216.00 K | $33.67 M | -29.18% | 0.36% |
NEW YORK STATE COMMON RETIREMENT FUND | 05/01/2025 | 204.48 K | $31.87 M | 0.00% | 0.34% |
SATURN V CAPITAL MANAGEMENT LLC | 05/15/2025 | 199.26 K | $31.06 M | 0.14% | 0.33% |
05/15/2025 | 195.52 K | $30.47 M | -9.31% | 0.33% | |
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 04/24/2025 | 189.61 K | $28.71 M | 24.14% | 0.32% |
PFM HEALTH SCIENCES, LP | 05/15/2025 | 186.92 K | $29.13 M | 256.76% | 0.31% |
JPMORGAN CHASE & CO | 05/12/2025 | 185.12 K | $28.85 M | 139.09% | 0.31% |
FINEPOINT CAPITAL LP | 05/14/2025 | 179.87 K | $28.03 M | -2.70% | 0.30% |
LOOMIS SAYLES & CO L P | 05/14/2025 | 174.91 K | $27.26 M | -2.23% | 0.29% |
UBS GROUP AG | 05/13/2025 | 173.84 K | $27.09 M | -22.97% | 0.29% |
ABRDN PLC | 05/13/2025 | 171.73 K | $26.77 M | -8.25% | 0.29% |
RESOLUTE CAPITAL ASSET PARTNERS LLC | 05/14/2025 | 167.50 K | $26.11 M | 46.29% | 0.28% |
RICE HALL JAMES & ASSOCIATES, LLC | 05/01/2025 | 160.80 K | $25.06 M | -1.89% | 0.27% |
DUQUESNE FAMILY OFFICE LLC | 05/15/2025 | 158.72 K | $24.74 M | -40.11% | 0.26% |
Ascendis Pharma A/S institutional Ownership - FAQ's
During the previous two years, 294 institutional investors and hedge funds held shares of Ascendis Pharma A/S. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 10.28 M
WESTFIELD CAPITAL MANAGEMENT CO LP: 5.48 M
Avoro Capital Advisors LLC: 5.22 M
FMR LLC: 4.67 M
JANUS HENDERSON GROUP PLC: 4.49 M
Artisan Partners Limited Partnership: 4.26 M
109.26% of Ascendis Pharma A/S stock is owned by institutional investors.
Institutional investors have bought a total of 68.37 M shares in the last 24 months. This purchase volume represents approximately $11.91 B in transactions.